Format: Livestream Symposium

1-3 of 3 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
Live
Livestream Symposium, Webcast
1
09/11/2025 at 5:15 PM EDT

Desmoid Tumors in Focus: Early Recognition, Evolving Therapies, and Nursing-Led Care Strategies

In this CE Concepts livestream symposium, expert faculty will guide learners to identify features and challenges of early diagnosis and treatment of DTs, evaluate the use of novel targeted therapies, and implement evidence-based strategies to monitor and manage AEs associated with systemic therapies for DTs to improve patient safety and adherence.

1
09/11/2025 at 5:15 PM EDT

Nicole Petrykowski, DNP, FNP-C, OCN

Nicole Petrykowski, DNP, FNP-C, OCN

Ravin Ratan, MD

Ravin Ratan, MD

Chair

The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1–Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations

In this CE Concepts live symposium, expert faculty will assess neuro-oncologic features of NF1, including tumor types and neurological signs, to support early recognition and guide clinical decision-making; evaluate the use of mitogen-activated protein kinase inhibitors in the management of NF1-associated plexiform neurofibromas in pediatric and adult patients, including team-based care to manage adverse events; and develop evidence-based, interprofessional care plans that reflect current clinical standards and support individualized, longitudinal management.

1.5
09/14/2025 at 3:30 PM EDT

Renie Moss

Renie Moss

Carlos Romo, MD

Carlos Romo, MD

Miriam Bornhorst, MD

Miriam Bornhorst, MD

Angela Hirbe, MD, PhD

Angela Hirbe, MD, PhD

Moderator

Live
Livestream Symposium, Symposium
1
09/27/2025 at 12:00 PM EDT

Livestream: MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management

In this CEC Oncology livestream, case-based symposium, expert faculty will discuss key characteristics of clinical presentation and disease advancement over a lifespan; review patient and caregiver education needs on the integration of MEK inhibitors in the management of NF1-associated PNs; and explore the role of nurses in comprehensive care plans, including disease monitoring, treatment personalization, toxicity management, and transitioning care of patients with NF1 across their lifespan.

1
09/27/2025 at 12:00 PM EDT

Sanita Burgic, MSN, APRN, AGNP-C

Sanita Burgic, MSN, APRN, AGNP-C

AeRang Kim, MD, PhD

AeRang Kim, MD, PhD

Amy Armstrong, MD

Amy Armstrong, MD